Clearpoint Neuro, Inc. (CLPT)

13.54 -0.28 (-1.99%) USD  |  NASDAQ  |  Dec 17, 16:00
13.64 +0.10 (+0.70%) After-Hours: 20:00
More

Clearpoint Neuro Research and Development Expense (Annual): 12.39M for Dec. 31, 2024

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for CLPT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Integra LifeSciences Holdings Corp. 54.43M
Masimo Corp. 222.80M
Phibro Animal Health Corp. 23.73M
Perspective Therapeutics, Inc. 39.33M
Xtant Medical Holdings, Inc. 2.385M